Resmed share price today

(RMD)

Resmed share price is $237.27 & ₹20,162.26 as on 21 Dec 2024, 2.30 'hrs' IST

$237.27

▲

5.69

(2.46%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Resmed share price in Dollar and Rupees. Guide to invest in Resmed from India. Also see the sentimental analysis on Indian investors investing in Resmed. Get details on the Indian mutual funds that are investing in Resmed. Get Analyst recommendations and forecasts along with all the Resmed's financials.

Resmed share price movements

Today's Low: $231.00
Today's High: $238.54
$237.27
2.64%
Downside
Day's Volatility :3.16%
Upside
0.53%
52 Weeks Low: $164.12
52 Weeks High: $260.49
$237.27
30.83%
Downside
52 Weeks Volatility :36.99%
Upside
8.91%

Resmed Returns

Period	Resmed Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-3.62%	-10.6%	0.0%
6 Months	30.23%	-6.0%	0.0%
1 Year	36.84%	2.2%	0.0%
3 Years	-9.46%	-0.9%	-21.1%

Resmed Key Statistics

in dollars & INR

Previous Close	$231.58
Open	$231.0
Today's High	$238.54
Today's Low	$231.0
Market Capitalization	$34.0B
Today's Volume	$2.3M
52 Week High	$260.49
52 Week Low	$164.1225
Revenue TTM	$4.8B
EBITDA	$1.6B
Earnings Per Share (EPS)	$7.55
PE Ratio	30.67
Dividend Yield	0.92%
Profit Margin	23.15%
Quarterly Earnings Growth YOY	0.42%
Return On Equity TTM	23.57%

How to invest in Resmed from India?

It is very easy for Indian residents to invest directly in Resmed from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Resmed stock in both Indian Rupees (INR) and US Dollars (USD). Search for Resmed or RMD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Resmed or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Resmed shares which would translate to 0.004 fractional shares of Resmed as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Resmed, in just a few clicks!

Returns in Resmed for Indian investors in Rupees

Investment Value

₹1,00,000

Resmed investment value today

Current value as on today

₹1,39,038

Returns

₹39,038

(+39.04%)

Returns from Resmed Stock

₹36,842 (+36.84%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Resmed

-11%

Period: Sep 23, 2024 to Dec 22, 2024. Change in 30 Days versus previous period

Search volume for Resmed on INDmoney from India has reduced in the last 30 days as on Dec 23, 2024. -11% less investors are searching Resmed in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Resmed

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	1263	-3.23	0.07%

Global Institutional Holdings in Resmed

Vanguard Group Inc
12.27%
BlackRock Inc
7.96%
State Street Corp
4.27%
Bank of New York Mellon Corp
3.89%
Morgan Stanley - Brokerage Accounts
3.05%
Geode Capital Management, LLC
2.63%

Analyst Recommendation on Resmed

Buy

63%Buy

36%Hold

0%Sell

Based on 19 Wall street analysts offering stock ratings for Resmed(by analysts ranked 0 to 5 stars)

Based on 19 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Resmed

What analysts predicted

Upside of 6.68%

Current:

$237.27

Target:

$253.11

Insights on Resmed

Price Movement
In the last 1 year, RMD stock has moved up by 38.4%
Increasing Revenue
Resmed Inc. has shown strong revenue growth over the last five quarters, increasing from $963.03 million to $1.22 billion. This represents an average quarterly increase of 5.6%.
Increasing Net Profit
Resmed Inc. has shown positive growth in its net profit over the last two quarters. The net profit increased from $292.23 million to $311.35 million, reflecting an average increase of 6.1% per quarter.
RMD vs ISRG (1 yr)
In the last 1 year, Intuitive Surgical, Inc. has given 56.0% return, outperforming this stock by 17.6%
RMD vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 44.1% return, outperforming this stock by 52.4%
Price to Sales
Resmed Inc. has a Price-to-Sales Ratio of 7.3, meaning that investors are willing to pay $7.3 for every $1 of sales the company generates. In comparison, Intuitive Surgical, Inc. has a much higher Price-to-Sales Ratio of 23.6, indicating that investors value its sales more highly. This shows that Resmed Inc.'s sales are currently seen as less expensive in relation to its market price compared to Intuitive Surgical.

Resmed Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$2.6B	↑ 11.38%
Net Income	$404.6M	↑ 28.2%
Net Profit Margin	15.52%	↑ 2.03%

	FY20	Y/Y Change
Revenue	$3.0B	↑ 13.44%
Net Income	$621.7M	↑ 53.65%
Net Profit Margin	21.02%	↑ 5.5%

	FY21	Y/Y Change
Revenue	$3.2B	↑ 8.11%
Net Income	$474.5M	↓ 23.67%
Net Profit Margin	14.84%	↓ 6.18%

	FY22	Y/Y Change
Revenue	$3.6B	↑ 11.93%
Net Income	$779.4M	↑ 64.26%
Net Profit Margin	21.78%	↑ 6.94%

	FY23	Y/Y Change
Revenue	$4.2B	↑ 18.02%
Net Income	$897.6M	↑ 15.15%
Net Profit Margin	21.25%	↓ 0.53%

	FY24	Y/Y Change
Revenue	$4.7B	↑ 10.95%
Net Income	$1.0B	↑ 13.75%
Net Profit Margin	21.79%	↑ 0.54%

	Q2 FY23	Q/Q Change
Revenue	$1.1B	↑ 0.46%
Net Income	$229.7M	↓ 1.22%
Net Profit Margin	20.47%	↓ 0.35%

	Q3 FY23	Q/Q Change
Revenue	$963.0M	↓ 14.17%
Net Income	$219.4M	↓ 4.46%
Net Profit Margin	22.78%	↑ 2.31%

	Q4 FY23	Q/Q Change
Revenue	$1.2B	↑ 20.74%
Net Income	$208.8M	↓ 4.84%
Net Profit Margin	17.96%	↓ 4.82%

	Q1 FY24	Q/Q Change
Revenue	$1.2B	↑ 2.94%
Net Income	$300.5M	↑ 43.91%
Net Profit Margin	25.1%	↑ 7.14%

	Q2 FY24	Q/Q Change
Revenue	$1.2B	↑ 2.19%
Net Income	$292.2M	↓ 2.75%
Net Profit Margin	23.89%	↓ 1.21%

	Q3 FY24	Q/Q Change
Revenue	$1.2B	↑ 0.11%
Net Income	$311.4M	↑ 6.54%
Net Profit Margin	25.43%	↑ 1.54%

	FY19	Y/Y Change
Profit	$1.5B	↑ 12.8%

	FY20	Y/Y Change
Profit	$1.7B	↑ 11.79%

	FY21	Y/Y Change
Profit	$1.8B	↑ 7.06%

	FY22	Y/Y Change
Profit	$2.0B	↑ 10.07%

	FY23	Y/Y Change
Profit	$2.4B	↑ 16.37%

	FY24	Y/Y Change
Profit	$2.7B	↑ 12.72%

	Q2 FY23	Q/Q Change
Profit	$617.4M	↓ 0.06%

	Q3 FY23	Q/Q Change
Profit	$600.1M	↓ 2.81%

	Q4 FY23	Q/Q Change
Profit	$646.9M	↑ 7.81%

	Q1 FY24	Q/Q Change
Profit	$681.6M	↑ 5.35%

	Q2 FY24	Q/Q Change
Profit	$704.3M	↑ 3.33%

	Q3 FY24	Q/Q Change
Profit	$717.2M	↑ 1.84%

	FY19	Y/Y Change
Operating Cash Flow	$459.1M	↓ 9.1%
Investing Cash Flow	$-1.1B	↑ 956.44%
Financing Cash Flow	$580.6M	↓ 156.55%

	FY20	Y/Y Change
Operating Cash Flow	$802.3M	↑ 74.76%
Investing Cash Flow	$-179.9M	↓ 83.28%
Financing Cash Flow	$-317.3M	↓ 154.64%

	FY21	Y/Y Change
Operating Cash Flow	$736.7M	↓ 8.17%
Investing Cash Flow	$-158.5M	↓ 11.9%
Financing Cash Flow	$-764.6M	↑ 140.99%

	FY22	Y/Y Change
Operating Cash Flow	$351.1M	↓ 52.34%
Investing Cash Flow	$-229.9M	↑ 45.09%
Financing Cash Flow	$-128.4M	↓ 83.21%

	FY23	Y/Y Change
Operating Cash Flow	$693.3M	↑ 97.44%
Investing Cash Flow	$-1.2B	↑ 404.46%
Financing Cash Flow	$422.9M	↓ 429.44%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$237.4M	↓ 15.97%
Investing Cash Flow	$-1.2B	↑ 4026.97%
Financing Cash Flow	$-188.6M	↓ 32.54%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$286.3M	↑ 20.57%
Investing Cash Flow	$-149.0M	↓ 87.16%
Financing Cash Flow	$-151.1M	↓ 19.86%

Resmed Technicals Summary

Sell

Neutral

Buy

Resmed is currently in a neutral trading position according to technical analysis indicators.

Resmed Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Resmed Inc.	-4.92%	30.23%	36.84%	-9.46%	52.3%
Intuitive Surgical, Inc.	-2.26%	22.23%	55.44%	43.84%	163.07%
Becton, Dickinson And Company	0.98%	-3.49%	-6.42%	-9.41%	-16.0%
West Pharmaceutical Services Inc	3.63%	0.12%	-7.26%	-28.87%	119.81%
Alcon Ag	-1.64%	-5.74%	9.38%	-3.45%	48.7%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Resmed Inc.	30.67	30.67	1.75	7.71	0.24	0.13	0.01	35.39
Intuitive Surgical, Inc.	84.09	84.09	3.89	6.85	0.16	0.08	NA	43.75
Becton, Dickinson And Company	38.13	38.13	1.02	13.11	0.06	0.03	0.02	89.47
West Pharmaceutical Services Inc	48.52	48.52	6.07	6.66	0.18	0.1	0.0	37.96
Alcon Ag	35.97	35.97	3.05	3.03	0.06	0.03	0.0	43.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Resmed Inc.	Buy	$34.0B	52.3%	30.67	23.15%
Intuitive Surgical, Inc.	Buy	$186.6B	163.07%	84.09	28.51%
Becton, Dickinson And Company	Buy	$64.7B	-16.0%	38.13	7.13%
West Pharmaceutical Services Inc	Buy	$23.7B	119.81%	48.52	17.37%
Alcon Ag	Buy	$41.6B	48.7%	35.97	11.89%

Resmed Dividend announcements

Resmed Dividends December, 2024
In the quarter ending December,2024. Resmed has declared dividend of $0.53
Read More

About Resmed

at resmed (nyse: rmd, asx: rmd) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. our cloud-connected medical devices transform care for people with sleep apnea, copd and other chronic diseases. our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. by enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.

Organization	Resmed
Employees	0
CEO	Mr. Michael J. Farrell BE, MBA, SM
Industry	Health Technology

Management People of Resmed

Name	Title
Mr. Michael J. Farrell BE, MBA, SM	CEO & Chairman
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD	Founder, Chair Emeritus & Director
Mr. Brett A. Sandercock	Chief Financial Officer
Mr. Michael J. Rider	Chief Legal Officer & Secretary
Mr. Justin Leong	Chief Product Officer
Mr. Kaushik Ghoshal	Chief Commercial Officer - SaaS
Mr. Alastair Robertson	Chief Information Officer
Mr. Jim Ellis	Chief Compliance Officer
Ms. Yvonne-Katrin Pucknat	Chief Marketing Officer
Ms. Vered Keisar	Chief People Officer

Important FAQs about investing in Resmed from India :

What is Resmed share price today?

Resmed share price today stands at $237.27, Open: $231.00 ; Previous Close: $231.58 ; High: $238.54 ; Low: $231.00 ; 52 Week High: $260.49 ; 52 Week Low: $164.12. The stock opens at $231.00, after a previous close of $231.58. The stock reached a daily high of $238.54 and a low of $231.00, with a 52-week high of $260.49 and a 52-week low of $164.12.

Can Indians buy Resmed shares?

Yes, Indians can invest in the Resmed (RMD) from India.

With INDmoney, you can buy Resmed at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Resmed at zero transaction cost.

How can I buy Resmed shares from India?

It is very easy to buy Resmed from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Resmed be purchased?

Yes, you can buy fractional shares of Resmed with INDmoney app.

What are the documents required to start investing in Resmed stocks?

To start investing in Resmed, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.